Ichiro Nakano

3.9k total citations · 1 hit paper
34 papers, 2.8k citations indexed

About

Ichiro Nakano is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Ichiro Nakano has authored 34 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Genetics. Recurrent topics in Ichiro Nakano's work include MicroRNA in disease regulation (9 papers), FOXO transcription factor regulation (9 papers) and Glioma Diagnosis and Treatment (8 papers). Ichiro Nakano is often cited by papers focused on MicroRNA in disease regulation (9 papers), FOXO transcription factor regulation (9 papers) and Glioma Diagnosis and Treatment (8 papers). Ichiro Nakano collaborates with scholars based in United States, South Korea and China. Ichiro Nakano's co-authors include Kaushal Joshi, Harley I. Kornblum, Biplab Dasgupta, Xiaona Liu, Rishi Raj Chhipa, Sung-Hak Kim, Jeongwu Lee, Do‐Hyun Nam, Jeremy N. Rich and Cheolju Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ichiro Nakano

34 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells

2013 626 citations Eun Hee Kim, Misuk Kim et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ichiro Nakano United States	28	1.9k	798	738	504	461	34	2.8k
Rajeev Vibhakar United States	33	2.1k 1.1×	660 0.8×	760 1.0×	421 0.8×	628 1.4×	98	2.9k
Alan H. Shih United States	25	2.7k 1.4×	694 0.9×	618 0.8×	443 0.9×	800 1.7×	37	3.8k
Giuseppe Lamorte Italy	22	1.5k 0.8×	804 1.0×	441 0.6×	245 0.5×	526 1.1×	44	2.5k
Hongwu Zheng United States	17	1.9k 1.0×	895 1.1×	587 0.8×	216 0.4×	429 0.9×	25	2.5k
Massimo Squatrito United States	26	2.0k 1.1×	822 1.0×	1.0k 1.4×	323 0.6×	845 1.8×	35	3.0k
Heather Maecker United States	14	1.7k 0.9×	1.2k 1.5×	587 0.8×	852 1.7×	213 0.5×	18	3.0k
Naoharu Takano Japan	23	1.3k 0.7×	595 0.7×	978 1.3×	348 0.7×	228 0.5×	45	2.5k
Xiaoguang Fang United States	22	2.0k 1.1×	1.1k 1.4×	1.2k 1.7×	723 1.4×	794 1.7×	22	3.4k
Pedro J. Real Spain	24	2.3k 1.3×	723 0.9×	389 0.5×	417 0.8×	312 0.7×	58	3.5k
Pierre de la Grange France	34	2.2k 1.2×	462 0.6×	630 0.9×	333 0.7×	196 0.4×	93	3.2k

Countries citing papers authored by Ichiro Nakano

Since Specialization

Citations

This map shows the geographic impact of Ichiro Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ichiro Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ichiro Nakano more than expected).

Fields of papers citing papers by Ichiro Nakano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ichiro Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ichiro Nakano. The network helps show where Ichiro Nakano may publish in the future.

Co-authorship network of co-authors of Ichiro Nakano

This figure shows the co-authorship network connecting the top 25 collaborators of Ichiro Nakano. A scholar is included among the top collaborators of Ichiro Nakano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ichiro Nakano. Ichiro Nakano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakashima, Hiroshi, Tran Nguyen, Kazue Kasai, et al.. (2018). Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma. Clinical Cancer Research. 24(11). 2574–2584. 49 indexed citations

Han, Jianfeng, Jianhong Chu, Wing Keung Chan, et al.. (2015). CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells. Scientific Reports. 5(1). 11483–11483. 280 indexed citations

Cheng, Peng, Emma Phillips, Sung-Hak Kim, et al.. (2015). Kinome-wide shRNA Screen Identifies the Receptor Tyrosine Kinase AXL as a Key Regulator for Mesenchymal Glioblastoma Stem-like Cells. Stem Cell Reports. 4(5). 899–913. 39 indexed citations

Hitomi, Masahiro, Xun Jin, Samuel J. Beck, et al.. (2015). The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Cell Death and Differentiation. 22(9). 1517–1525. 41 indexed citations

Alvarado, Alvaro G., Soumya M. Turaga, Pratheesh Sathyan, et al.. (2015). Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling. Neuro-Oncology. 18(5). 656–666. 32 indexed citations

Jeon, Hye-Min, Sung-Hak Kim, Xun Jin, et al.. (2014). Crosstalk between Glioma-Initiating Cells and Endothelial Cells Drives Tumor Progression. Cancer Research. 74(16). 4482–4492. 70 indexed citations

Liu, Xiaona, Rishi Raj Chhipa, Ichiro Nakano, & Biplab Dasgupta. (2014). The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent. Molecular Cancer Therapeutics. 13(3). 596–605. 233 indexed citations

Minata, Mutsuko, Chunyu Gu, Kaushal Joshi, et al.. (2014). Multi-Kinase Inhibitor C1 Triggers Mitotic Catastrophe of Glioma Stem Cells Mainly through MELK Kinase Inhibition. PLoS ONE. 9(4). e92546–e92546. 34 indexed citations

Nakano‐Okuno, Mariko, B. Borah, & Ichiro Nakano. (2014). Ethics of iPSC-Based Clinical Research for Age-Related Macular Degeneration: Patient-Centered Risk-Benefit Analysis. Stem Cell Reviews and Reports. 10(6). 743–752. 16 indexed citations

10.

Markant, Shirley L., Lourdes Adriana Esparza, Marat S. Pavlyukov, et al.. (2014). Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Oncogene. 34(29). 3770–3779. 49 indexed citations

11.

Kim, Jun-Kyum, Xiong Jin, Young-Woo Sohn, et al.. (2014). Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling. Cancer Letters. 353(2). 194–200. 62 indexed citations

12.

Vo, Dat T., Philip J. Uren, Qiao Mei, et al.. (2014). Genomic Analyses Reveal Broad Impact of miR-137 on Genes Associated with Malignant Transformation and Neuronal Differentiation in Glioblastoma Cells. PLoS ONE. 9(1). e85591–e85591. 37 indexed citations

13.

Waghmare, Indrayani, et al.. (2014). Intercellular Cooperation and Competition in Brain Cancers: Lessons FromDrosophilaand Human Studies. Stem Cells Translational Medicine. 3(11). 1262–1268. 20 indexed citations

14.

Kim, Eun Hee, Misuk Kim, Dong‐Hun Woo, et al.. (2013). Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells. Cancer Cell. 23(6). 839–852. 626 indexed citations breakdown →

15.

Pavlyukov, Marat S., Kaushal Joshi, Habibe Kurt, et al.. (2012). Impairment of Glioma Stem Cell Survival and Growth by a Novel Inhibitor for Survivin–Ran Protein Complex. Clinical Cancer Research. 19(3). 631–642. 79 indexed citations

16.

Kim, Tae Hyong, Jieun Song, Sheila R. Alcantara Llaguno, et al.. (2012). Suppression of Peroxiredoxin 4 in Glioblastoma Cells Increases Apoptosis and Reduces Tumor Growth. PLoS ONE. 7(8). e42818–e42818. 54 indexed citations

17.

Jin, Xun, Xiong Jin, Young-Woo Sohn, et al.. (2012). Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27KIP1 and MMP3 expression. Cancer Letters. 328(2). 235–242. 27 indexed citations

18.

Ammirati, Mario, et al.. (2012). A streamlined protocol for the use of the semi-sitting position in neurosurgery: A report on 48 consecutive procedures. Journal of Clinical Neuroscience. 20(1). 32–34. 42 indexed citations

19.

Jijiwa, Mayumi, Habibe Demir, Snehalata Gupta, et al.. (2011). CD44v6 Regulates Growth of Brain Tumor Stem Cells Partially through the AKT-Mediated Pathway. PLoS ONE. 6(9). e24217–e24217. 112 indexed citations

20.

Nakano, Ichiro, Kamaldeep Joshi, Koppany Visnyei, et al.. (2011). Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway. Neuro-Oncology. 13(6). 622–634. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact